Hims & Hers Health (HIMS) is quickly becoming one of the most compelling stories in the market as an emerging powerhouse in the direct-to-consumer healthcare space. The stock has posted outsized gains ...

DXC Technology (DXC) has struggled to gain traction in recent years, as persistent revenue declines and a sluggish business transformation have weighed heavily on both its fundamentals and its stock ...